Skip to content
10-Q

Quarterly Report

Gala Pharmaceutical Inc.

0001683168-19-001231

← back to feed
Filed
Apr 30, 2019 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2019 · Apr 18, 2019 107.67M sh
Capex Q1 2019 · Feb 28, 2019 $6.7K
Capex Q1 2019 · Feb 28, 2018 $0
Operating Cash Flow Q1 2019 · Feb 28, 2019 −$107.7K
Operating Cash Flow Q1 2019 · Feb 28, 2018 −$82.6K
Cash And Equivalents Q1 2019 · Feb 28, 2019 $179.29K
Cash And Equivalents Q1 2019 · Nov 30, 2018 $116.2K
Cash And Equivalents Q1 2019 · Feb 28, 2018 $168
Cash And Equivalents Q1 2019 · Nov 30, 2017 $7.77K
Stockholders Equity Q1 2019 · Feb 28, 2019 −$1.28M
Stockholders Equity Q1 2019 · Nov 30, 2018 −$811.23K
Total Liabilities Q1 2019 · Feb 28, 2019 $1.63M
Total Liabilities Q1 2019 · Nov 30, 2018 $1.12M
Current Assets Q1 2019 · Feb 28, 2019 $243.49K
Current Assets Q1 2019 · Nov 30, 2018 $227K
Total Assets Q1 2019 · Feb 28, 2019 $282.63K
Total Assets Q1 2019 · Nov 30, 2018 $262.16K
Sga Expense Q1 2019 · Feb 28, 2019 $38.67K
Sga Expense Q1 2019 · Feb 28, 2018 $36.26K
Net Income Q1 2019 · Feb 28, 2019 −$577.17K
Net Income Q1 2019 · Feb 28, 2018 −$583.24K
Gross Profit Q1 2019 · Feb 28, 2019 $0
Gross Profit Q1 2019 · Feb 28, 2018 $0
Cost Of Revenue Q1 2019 · Feb 28, 2019 $0
Cost Of Revenue Q1 2019 · Feb 28, 2018 $0
Revenue Q1 2019 · Feb 28, 2019 $0
Revenue Q1 2019 · Feb 28, 2018 $0